We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PerkinElmer First to Introduce GMP Compliant Lutetium-177 Nuclide

News   Jun 01, 2010

 
PerkinElmer First to Introduce GMP Compliant Lutetium-177 Nuclide
 
 
 

RELATED ARTICLES

Some Cancer Drugs Don’t Work by Hitting Their Targets

News

Some cancer drug candidates in clinical trials kill cancerous cells through off-target effects instead of by interacting with their intended molecular targets, according to new study findings.

READ MORE

Hidden Differences May Help Cells Evade Drug Therapy

News

Seemingly identical cells can use different protein molecules to carry out the same function in an important cellular process. Scientists have named this variability “functional mosaicism”. It could have significant implications for the development of therapeutic treatments.

READ MORE

Drug That Combats Memory Loss in Alzheimer's Enters Phase II Trials

News

A new drug may protect against memory loss, nerve damage and other symptoms of Alzheimer's disease. The drug called BPN14770 is now in Phase 2 clinical trials in patients with Alzheimer's and Fragile X syndrome.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE